deferoxamine has been researched along with Diffuse Parenchymal Lung Disease in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyakawa, H | 1 |
Mason, RP | 1 |
Jiang, J | 1 |
Kadiiska, MB | 1 |
Wang, XJ | 1 |
Yin, QS | 1 |
Wei, XD | 1 |
Rego, EM | 1 |
Neto, EB | 1 |
Simões, BP | 1 |
Zago, MA | 1 |
1 review available for deferoxamine and Diffuse Parenchymal Lung Disease
Article | Year |
---|---|
[Deferoxamine-induced interstitial pulmonary injury: a case report and literature review].
Topics: Adult; Deferoxamine; Humans; Lung Diseases, Interstitial; Male; Myelodysplastic Syndromes | 2012 |
2 other studies available for deferoxamine and Diffuse Parenchymal Lung Disease
Article | Year |
---|---|
Lipid-derived free radical production in superantigen-induced interstitial pneumonia.
Topics: Allopurinol; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Cell Movement; Deferoxamine; | 2009 |
Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine.
Topics: Adolescent; beta-Thalassemia; Child; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; | 1998 |